vimarsana.com

Page 42 - இதழ் ஆஃப் தி அமெரிக்கன் கல்லூரி இருதயவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Myocardial Solutions technology helps clinicians detect asymptomatic cardiac dysfunction

MORRISVILLE – In new research findings published in the Journal of the American College of Cardiology (JACC) Cardiovascular Imaging, scientists found that the technology developed by Triangle startup Myocardial Solutions was able to differentiate between healthy patients and patients who were at risk of heart failure though they were not displaying symptoms. MyoStrain, which has received FDA-510(k) pre-market clearance and is commercially available in the United States and in Europe, is a proprietary MRI software developed by the company.  The technology provides clinicians with novel cardiac information to proactively detect, manage and monitor patient heart health, according to a spokesperson for the company, Ahmed Osman. The process takes less than 10 minutes and is non-invasive, and yields a personalized patient heart health report.

Support health equity by ending America s amputation epidemic

© Getty Images As we recognize National Minority Health Month, a time designated to examine the systemic inequities in our nation’s health care system, we must take a close look at the imbalances that have been exposed even further because of the COVID-19 pandemic. Once hidden to the unaffected, it’s now clear to all that communities of color including the Black community have suffered from harmful barriers to comprehensive care, underinvestment, and a severe trust deficit due to discriminatory practices. Throw in social determinants of health many of which are linked to slavery, segregation, and structural racism and it’s little wonder that Black Americans are unduly affected by the pandemic. Not only are we more likely to be infected by SARS-CoV-2, but we are also more likely to die from it and are less likely to have access to the groundbreaking vaccines approved for use in the U.S.

Pneumonia in HF Patients Is Common, Lethal, and Preventable

April 19, 2021 For patients with heart failure, the risk of dying after an episode of pneumonia is up to fourfold higher than if they had not contracted the disease, with the risk for vascular events and death remaining high for months after recovery, according to a post hoc analysis of the PARADIGM-HF and PARAGON-HF trials. While pneumonia is typically considered an acute illness, prior research has documented a link to subsequent ACS; whether it can also exert long-term risks for heart failure was unclear, the authors say. And while pneumonia vaccines against the two most-common strains are widely available and vaccination is recommended in HF guidelines, uptake has been poor.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.